David Booth

4.6k total citations · 1 hit paper
35 papers, 2.9k citations indexed

About

David Booth is a scholar working on Hepatology, Epidemiology and Immunology. According to data from OpenAlex, David Booth has authored 35 papers receiving a total of 2.9k indexed citations (citations by other indexed papers that have themselves been cited), including 20 papers in Hepatology, 13 papers in Epidemiology and 11 papers in Immunology. Recurrent topics in David Booth's work include Hepatitis C virus research (20 papers), Hepatitis B Virus Studies (10 papers) and Liver Disease Diagnosis and Treatment (9 papers). David Booth is often cited by papers focused on Hepatitis C virus research (20 papers), Hepatitis B Virus Studies (10 papers) and Liver Disease Diagnosis and Treatment (9 papers). David Booth collaborates with scholars based in Australia, United Kingdom and Italy. David Booth's co-authors include Jacob George, Golo Ahlenstiel, Vijayaprakash Suppiah, Graeme J. Stewart, Gregory J. Dore, Thomas Berg, Martin Weltman, Maria Lorena Abate, Ulrich Spengler and Tobias Müller and has published in prestigious journals such as Nature Communications, Nature Genetics and Hepatology.

In The Last Decade

David Booth

35 papers receiving 2.8k citations

Hit Papers

IL28B is associated with ... 2009 2026 2014 2020 2009 400 800 1.2k

Author Peers

Peers are selected by citation overlap in the author's most active subfields. citations · hero ref

Author Last Decade Papers Cites
David Booth 1.8k 1.5k 708 658 473 35 2.9k
Guadalupe Ercilla 1.4k 0.8× 1.3k 0.9× 297 0.4× 414 0.6× 436 0.9× 69 2.7k
Ya‐Hui Chuang 1.1k 0.6× 886 0.6× 362 0.5× 905 1.4× 414 0.9× 77 2.6k
Alain Chevailler 485 0.3× 685 0.5× 285 0.4× 841 1.3× 269 0.6× 87 2.2k
Eiji Mita 2.4k 1.3× 2.0k 1.4× 540 0.8× 275 0.4× 480 1.0× 120 3.3k
Massimo Fiorilli 539 0.3× 584 0.4× 468 0.7× 1.1k 1.7× 328 0.7× 118 2.5k
Rozanne C. de Veer 2.0k 1.1× 1.9k 1.3× 1.4k 1.9× 203 0.3× 93 0.2× 37 3.8k
Natacha Patey 202 0.1× 918 0.6× 425 0.6× 1.5k 2.2× 136 0.3× 38 3.2k
M. Meltzer 579 0.3× 343 0.2× 390 0.6× 374 0.6× 518 1.1× 9 1.9k
Kiyoshi Mochizuki 1.2k 0.6× 1.1k 0.8× 322 0.5× 439 0.7× 119 0.3× 44 1.9k
S. John Swanson 474 0.3× 753 0.5× 239 0.3× 998 1.5× 56 0.1× 45 3.2k

Countries citing papers authored by David Booth

Since Specialization
Citations

This map shows the geographic impact of David Booth's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by David Booth with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites David Booth more than expected).

Fields of papers citing papers by David Booth

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by David Booth. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by David Booth. The network helps show where David Booth may publish in the future.

Co-authorship network of co-authors of David Booth

This figure shows the co-authorship network connecting the top 25 collaborators of David Booth. A scholar is included among the top collaborators of David Booth based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with David Booth. David Booth is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Read, Scott, Ratna Sari Wijaya, Mehdi Ramezani–Moghadam, et al.. (2019). Macrophage Coordination of the Interferon Lambda Immune Response. Frontiers in Immunology. 10. 2674–2674. 51 indexed citations
2.
Read, Scott, Kate O'Connor, Vijayaprakash Suppiah, et al.. (2017). Zinc is a potent and specific inhibitor of IFN-λ3 signalling. Nature Communications. 8(1). 15245–15245. 50 indexed citations
3.
Mina, Michael, Fabio Luciani, Barbara Cameron, et al.. (2015). Resistance to hepatitis C virus: potential genetic and immunological determinants. The Lancet Infectious Diseases. 15(4). 451–460. 18 indexed citations
4.
O'Connor, Kate, Jacob George, David Booth, & Golo Ahlenstiel. (2014). Dendritic cells in hepatitis C virus infection: Key players in theIFNL3-genotype response. World Journal of Gastroenterology. 20(47). 17830–17838. 8 indexed citations
5.
Eslam, Mohammed, Reynold Leung, Manuel Romero‐Gómez, et al.. (2014). IFNL3 polymorphisms predict response to therapy in chronic hepatitis C genotype 2/3 infection. Journal of Hepatology. 61(2). 235–241. 29 indexed citations
6.
Roberts, Stuart K., Joanne Mitchell, Reynold Leung, et al.. (2013). Distribution of interferon lambda‐3 gene polymorphisms in Australian patients with previously untreated genotype 1 chronic hepatitis C: Analysis from the PREDICT and CHARIOT studies. Journal of Gastroenterology and Hepatology. 29(1). 179–184. 5 indexed citations
7.
O'Connor, K., Grant P. Parnell, Ellis Patrick, et al.. (2013). Hepatic metallothionein expression in chronic hepatitis C virus infection is IFNL3 genotype-dependent. Genes and Immunity. 15(2). 88–94. 20 indexed citations
8.
Ahlenstiel, Golo, David Booth, & Jacob George. (2012). Will IL28B polymorphisms remain relevant to direct-acting antiviral treatment paradigms?. Antiviral Therapy. 17(6 Pt B). 1163–1170. 5 indexed citations
9.
Fischer, Janett, Stephan Böhm, Markus Scholz, et al.. (2012). Combined effects of different interleukin-28B gene variants on the outcome of dual combination therapy in chronic hepatitis C virus type 1 infection. Hepatology. 55(6). 1700–1710. 66 indexed citations
10.
Petta, Salvatore, Chiara Rosso, Reynold Leung, et al.. (2012). Effects of IL28B rs12979860 CC Genotype on Metabolic Profile and Sustained Virologic Response in Patients With Genotype 1 Chronic Hepatitis C. Clinical Gastroenterology and Hepatology. 11(3). 311–317.e1. 26 indexed citations
11.
Frydrych, Agnieszka M., et al.. (2010). Oral cavity squamous cell carcinoma survival by biopsy type: a cancer registry study. Australian Dental Journal. 55(4). 378–384. 5 indexed citations
12.
Afdhal, Nezam H., John G. McHutchison, Stefan Zeuzem, et al.. (2010). Hepatitis C pharmacogenetics: State of the art in 2010. Hepatology. 53(1). 336–345. 115 indexed citations
13.
Touitou, Isabelle, Tamara Sarkisian, Myrna Medlej‐Hashim, et al.. (2007). Country as the primary risk factor for renal amyloidosis in familial mediterranean fever. Arthritis & Rheumatism. 56(5). 1706–1712. 188 indexed citations
14.
Slack‐Smith, Linda, et al.. (2002). Arthritis and Use of Dental Services: A Population Based Study. Australian Dental Journal. 47(3). 208–213. 29 indexed citations
15.
Aganna, Ebun, Avraham Zeharia, G. A. Hitman, et al.. (2002). An Israeli Arab patient with a de novoTNFRSF1A mutation causing tumor necrosis factor receptor-associated periodic syndrome. Arthritis & Rheumatism. 46(1). 245–249. 23 indexed citations
16.
Booth, David. (2000). The genetic basis of autosomal dominant familial Mediterranean fever. QJM. 93(4). 217–221. 138 indexed citations
17.
Farah, Camile S., et al.. (1999). Dental maturity of children in Perth, Western Australia, and its application in forensic age estimation. Journal of Clinical Forensic Medicine. 6(1). 14–18. 51 indexed citations
18.
Booth, David. (1998). Pyrin/marenostrin mutations in familial Mediterranean fever. QJM. 91(9). 603–606. 90 indexed citations
19.
Farah, Camile S., et al.. (1996). Age determination of children in Western Australia; (Four teeth system). Journal of Dental Research. 75(5). 1077–1077. 2 indexed citations
20.
Singer, Steven W., Paul V. Abbott, & David Booth. (1991). Idiopathic coronal radiolucencies in unerupted permanent teeth. Case reports. Australian Dental Journal. 36(1). 32–37. 10 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026